Does Medicare Cover Varicose Vein Treatment? Full Guide

Medicare varicose vein treatment coverage turns on a single question that no other common condition frames quite so starkly: is this procedure medically necessary, or is it cosmetic? Roughly one in three adults over 65 has visible varicose veins, and chronic venous insufficiency — the underlying valve failure that causes them — is among the most common circulatory conditions in the Medicare population. Medicare covers the modern treatments (endovenous ablation, medical-grade sclerotherapy, phlebectomy) generously when the disease is causing documented symptoms, and covers nothing at all when the veins are merely visible. Vein clinics have built an entire industry in the space between those two sentences, which is exactly why understanding the coverage rules before your first “free vein screening” matters.

This guide explains when Medicare pays for vein treatment, which procedures are covered under Part B, what the conservative-therapy requirement means in practice, what you’ll pay with and without supplemental coverage, and how to recognize when a vein clinic is treating your insurance rather than your legs.

Varicose Veins and Chronic Venous Insufficiency: Why This Is a Medicare-Age Disease

Leg veins return blood to the heart against gravity using one-way valves. When those valves fail — from age, genetics, prior pregnancies, obesity, prior blood clots, or years of standing occupations — blood flows backward (reflux) and pools in the leg. The visible result is varicose veins: bulging, rope-like veins, most often fed by a leaky great or small saphenous vein. The clinical condition is chronic venous insufficiency (CVI), and it is progressive:

• Early: visible varicose veins, aching, heaviness, and fatigue that worsen through the day and with standing, and improve with elevation
• Moderate: chronic ankle and calf swelling, night cramps, itching, and restless legs
• Advanced: skin changes around the ankle — brownish discoloration (hemosiderin staining), firm thickened skin (lipodermatosclerosis), and eczema-like inflammation
• End-stage: venous leg ulcers — open wounds near the ankle that heal slowly and recur in about half of patients without ongoing treatment

That last stage is why venous disease is not cosmetic. Venous ulcers are the most common chronic wound in the Medicare population, and treating the upstream reflux is one of the few interventions proven to prevent them. Our Medicare wound care guide covers the ulcer stage in depth; this article covers everything upstream of it.

One important distinction up front: venous disease is the mirror image of peripheral artery disease. PAD is blood failing to reach the leg (pain with walking, relieved by rest and dangling); venous disease is blood failing to leave it (aching and swelling with standing, relieved by elevation). Many Medicare patients have both, and the distinction changes treatment entirely — compression helps venous disease but can be dangerous in severe PAD. A proper vascular workup checks for both.

The Coverage Rule: Medically Necessary vs. Cosmetic

Medicare never covers cosmetic treatment. For vein disease, the line is drawn by Medicare’s regional contractors through local coverage determinations (LCDs), and while wording varies by region, the core requirements are consistent:

1. Documented symptoms attributable to the veins — persistent aching, heaviness, or cramping that interferes with daily activities; chronic swelling; skin changes; bleeding from a varicosity; superficial vein clots (thrombophlebitis); or an active or healed venous ulcer. Appearance alone — no matter how prominent the veins — does not qualify.
2. Documented reflux on a venous duplex ultrasound — the study must show valve incompetence in the vein to be treated (typically reflux lasting longer than half a second in a saphenous vein), performed with you standing or tilted upright. A scan done lying flat can miss reflux entirely.
3. A failed trial of conservative therapy — most contractors require 6 to 12 weeks of documented conservative measures (compression stockings, leg elevation, exercise, weight management, analgesics) before authorizing a procedure. If symptoms persist despite that trial, procedural treatment becomes medically necessary.

Spider veins (telangiectasias) are always cosmetic in Medicare’s eyes. Injection of spider veins (CPT 36468) is a statutory exclusion in practice — no symptom documentation changes it. A clinic that offers to “find a way” to bill spider vein treatment to Medicare is describing fraud, and you would be liable for the bill when the claim unravels.

The conservative-therapy requirement contains a genuine trap worth knowing: Medicare requires you to try compression stockings first, but does not pay for them. As we explain in the wound care guide’s compression section, gradient compression stockings are only covered when you have an open venous ulcer (or a lymphedema diagnosis, since 2024). For the conservative trial, expect to buy your own — $30 to $80 per pair over the counter. Keep the receipts and note the dates; your doctor’s documentation of the trial is what unlocks procedure coverage.

Part B Diagnostics: The Venous Duplex Ultrasound

The venous reflux study is the gate everything else passes through. Medicare Part B covers duplex ultrasound of the leg veins when ordered to evaluate symptoms — swelling, skin changes, suspected reflux, or to rule out a deep vein clot. After the annual Part B deductible ($283 in 2026), you pay 20 percent coinsurance — typically $30 to $80 per study in an office or vascular lab setting.

Two things make this study worth doing well. First, it maps which veins are refluxing — great saphenous, small saphenous, perforators, or deep veins — and that map determines which procedures are appropriate and covered. Second, it distinguishes superficial reflux (fixable with ablation) from deep-vein reflux or obstruction (which ablation does not fix, and which usually traces back to an old deep vein thrombosis). If a clinic goes straight from a glance at your legs to scheduling ablation without a standing reflux study, that is your cue to leave.

Covered Procedures Under Part B

Modern vein treatment is office-based, walk-in-walk-out, and covered under Part B when the medical-necessity criteria are met. The era of hospital vein stripping under general anesthesia is essentially over.

Endovenous thermal ablation — the workhorse

The standard treatment for saphenous reflux is endovenous ablation: a thin catheter is threaded up the faulty vein under ultrasound guidance, and the vein is sealed shut from the inside using heat — either radiofrequency (RFA, CPT 36475 for the first vein, 36476 for additional veins in the same leg) or laser (EVLT, CPT 36478/36479). Blood reroutes through healthy veins immediately. The procedure takes under an hour under local anesthetic, and success rates exceed 90 percent.

Medicare pays office-based ablation at a global rate; your 20 percent coinsurance typically runs $300 to $500 per vein treated in an office setting, and more in a hospital outpatient department where a facility fee is added. This is worth asking about in advance — the same procedure by the same physician can cost you two to three times more in a hospital-based clinic.

Non-thermal ablation — VenaSeal, foam, and mechanochemical

Newer non-thermal options avoid heat (and therefore the anesthetic injections along the vein):

• Cyanoacrylate closure (VenaSeal, CPT 36482/36483**)** — medical adhesive seals the vein. Covered by Medicare in most regions, though some contractors apply extra criteria; confirm coverage before scheduling.
• Ultrasound-guided foam sclerotherapy with commercial polidocanol microfoam (Varithena, CPT 36465/36466**)** — covered for saphenous reflux meeting the standard criteria.
• Mechanochemical ablation (ClariVein, CPT 36473/36474**)** — a rotating wire plus sclerosant; coverage varies more by contractor than the others.

For most patients the clinical results are comparable to thermal ablation. If your plan or contractor treats one modality more restrictively, the thermal options are the safest coverage bet.

Sclerotherapy and phlebectomy — cleaning up the branches

Sealing the saphenous trunk often leaves bulging surface branches that need direct treatment:

• Ambulatory phlebectomy (CPT 37765/37766) — removing surface varicosities through 2–3 mm nicks. Covered when the veins are symptomatic and part of a documented treatment plan.
• Sclerotherapy of incompetent veins (CPT 36470 single vein / 36471 multiple) — injections that scar symptomatic varicose branches closed. Covered under the same medical-necessity umbrella — and categorically distinct from cosmetic spider-vein injections, which are not.

Many treatment plans are staged: ablation first, then phlebectomy or sclerotherapy of residual branches weeks later, then the other leg. Each stage generates its own 20 percent coinsurance, which is how a “minor office procedure” becomes a $1,500–$3,000 out-of-pocket year without supplemental coverage.

Ligation and stripping — the legacy operation

High ligation and stripping of the saphenous vein (CPT 37718/37722) is still covered — under Part B as outpatient surgery, or under Part A in the rare case it requires admission — but it has been almost entirely replaced by ablation, which works as well with far less recovery. If a surgeon proposes stripping as the first option without explaining why ablation won’t work for your anatomy, get a second opinion.

Beyond the Basics: Clots, Ulcers, and Deep Vein Disease

Superficial vein thrombosis (SVT) — a painful, cord-like clot in a varicose vein — is common in untreated venous disease. Part B covers the diagnostic ultrasound (which matters because clots near the deep system can extend into a DVT), and treatment with anticoagulants for larger superficial clots is covered under Part D — typically a modern oral anticoagulant for around 45 days. Our atrial fibrillation guide covers how Part D handles the anticoagulant class in detail.

Venous ulcers change the coverage calculus entirely. Once an ulcer is open, compression becomes a covered surgical dressing benefit, wound center care begins, and — critically — early ablation of the underlying reflux is covered and speeds ulcer healing (this is settled evidence, not an upsell: randomized trials showed faster healing and less recurrence when ablation is done promptly rather than after healing). If you have a venous ulcer and your wound center has not referred you for a reflux study and ablation, ask directly. The full ulcer pathway — dressings, compression, skin substitutes, home health — is in the wound care guide.

Deep venous obstruction — usually scarring from an old DVT or compression of the iliac vein in the pelvis — causes severe swelling that superficial ablation cannot fix. Venography and iliac vein stenting are covered under Part B when criteria are met, though this is a specialized area where documentation requirements are stricter and second opinions are particularly valuable.

Weight management deserves a mention as the modifiable risk factor: obesity raises venous pressure directly and worsens every stage of CVI. Medicare’s expanding coverage of weight-management care, including GLP-1 drugs for qualifying beneficiaries, is covered in our Ozempic and weight loss guide.

What Vein Treatment Costs Under Medicare

The structural point: vein treatment is rarely one procedure. A typical medically necessary course — reflux study, ablation of one or two truncal veins, staged phlebectomy, follow-up ultrasounds, then the same for the other leg — accumulates coinsurance at every step. Medigap Plan G reduces all of it to zero after the Part B deductible, which is why patients planning definitive treatment of both legs should price supplemental coverage against the full treatment plan, not a single procedure.

Medicare Advantage enrollees face a different landscape: vein procedures are among the most heavily prior-authorized services in MA, precisely because the field has a history of overuse. Expect the plan to demand the duplex report, symptom documentation, and the conservative-therapy trial before approving ablation — and expect denials for non-thermal modalities in some plans. Copays per procedure, multiplied across a staged plan, can approach Original Medicare’s coinsurance. Network rules also matter, since vein care spans vascular surgery, interventional radiology, and phlebology clinics; see Medicare Advantage HMO vs. PPO for how referral and network rules differ. If your income is limited, a Medicare Savings Program can eliminate Part B cost-sharing entirely.

The Vein Clinic Problem: How to Protect Yourself

Vein treatment is profitable, office-based, and high-volume — a combination that has attracted both excellent specialists and assembly-line operators. Federal enforcement actions against vein clinics for medically unnecessary ablations are a recurring news item. Red flags worth taking seriously:

• “Free vein screenings” marketed to seniors — the screening is free; the treatment plan it generates rarely is
• A treatment plan produced before a standing reflux ultrasound, or one that proposes ablating veins the duplex shows are competent
• Every patient needs 4+ ablations — perforator ablations and repeat procedures stacked without symptom justification
• Spider-vein treatment “billed through insurance” — it is cosmetic, and billing it otherwise is fraud with your name on the claim
• No mention of conservative therapy — a clinic skipping the compression trial is skipping the documentation Medicare requires, and the denial lands on you

The counterweight is simple: a board-certified vascular surgeon or interventional specialist who shows you your reflux map, explains which veins are causing which symptoms, and starts with the conservative trial is practicing exactly the medicine Medicare’s rules are designed to pay for.

Seven Steps if Your Legs Ache, Swell, or Show Varicose Veins

1. Start with your primary care doctor, not a vein clinic ad. Ask for a referral to a vascular lab for a standing venous reflux study — Part B covers it.
2. Get both systems checked. Ask whether the workup covers arterial disease too (ABI testing) — the treatments differ, and compression needs arterial clearance in some patients.
3. Do the conservative trial properly and keep records. Buy the compression stockings, wear them, log the weeks and symptoms. This documentation is the key that unlocks procedure coverage.
4. If symptoms persist, ask specifically about office-based ablation — and ask whether the facility bills as an office or a hospital outpatient department, because your coinsurance can differ by hundreds of dollars per procedure.
5. Get the full staged plan in writing — which veins, which procedures, how many sessions, both legs — and price your total 20 percent exposure before you start.
6. If you have skin changes or a healed ulcer at the ankle, treat reflux as urgent, not elective — ablation now is what prevents the wound care pathway later.
7. If anyone proposes treating veins that don’t hurt, swell, or show skin changes, get a second opinion. The rule of thumb mirrors Medicare’s: treat the symptoms, not the mirror.

Frequently Asked Questions

Does Medicare cover varicose vein removal? Yes, when it’s medically necessary: documented symptoms (pain, swelling, skin changes, bleeding, clots, or ulcers), reflux confirmed on a standing duplex ultrasound, and a failed trial of conservative therapy (usually 6–12 weeks of compression). Purely cosmetic treatment is never covered.

Does Medicare cover laser treatment or radiofrequency ablation for veins? Yes — endovenous laser (EVLT) and radiofrequency ablation (RFA) are the standard covered treatments for saphenous vein reflux under Part B. You pay 20 percent coinsurance after the deductible; a Medigap plan reduces that to zero.

Does Medicare pay for compression stockings for varicose veins? No — with two exceptions. Stockings are covered only when you have an open venous stasis ulcer (as a surgical dressing) or a lymphedema diagnosis (under the 2024 Lymphedema Treatment Act). For prevention and for the required conservative-therapy trial, you buy your own.

Does Medicare cover spider vein treatment? No. Spider vein (telangiectasia) injection is cosmetic and excluded regardless of documentation. Be wary of any clinic that suggests otherwise — the repayment liability lands on you.

How much does vein ablation cost with Medicare? In an office setting, the 20 percent Part B coinsurance typically runs $300–$500 per vein treated, after the $283 annual deductible. Hospital-based clinics add a facility fee that can double or triple that. A complete staged plan for both legs commonly reaches $1,500–$3,000 out of pocket without Medigap — and $0 beyond the deductible with Medigap Plan G.

Will treating my varicose veins prevent leg ulcers? It substantially lowers the risk. Ablating documented reflux reduces venous pressure, and in patients who already have an ulcer, early ablation is proven to speed healing and reduce recurrence. If you have ankle skin darkening or a prior ulcer, reflux treatment is preventive medicine, not cosmetics.

Chronic venous insufficiency sits on a spectrum this site now covers end to end — from the first aching, swollen evenings through wound care for venous ulcers and the arterial disease that so often coexists with it. Medicare’s rules here are unusually rational: prove the disease, try the simple things first, then the effective procedures are covered. The patients who fare worst are the ones who either suffer for years assuming vein treatment is cosmetic — or walk into a free screening and receive a treatment plan their legs never asked for.